Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Post-stroke cognitive impairments: diagnosis and therapeutic approaches

https://doi.org/10.14412/2074-2711-2013-2360

Full Text:

Abstract

Stroke is a leading cause of disability not only due to its impact on motor or sensory functions, but also to post-stroke cognitive impairments (CI). Within the first year after stroke, the rate of CI may be as high as 80-90% and 7-23% of patients develop dementia. The most important risk factors for CI are strokes, their extent, site, and number. Old age, low education level, severe previous pathological changes in the brain parenchyma, diabetes mellitus, atrial fibrillations, and recurrent strokes in particular, are associated with an increased risk of CI. Examining cognitive functions, monitoring the evolution of cognitive deficit, and post-stroke rehabilitation are indicated in patients who have had stroke. The main treatments in patients with CI are secondary stroke prevention, including lifestyle modification and symptomatic therapy. Sermion is one of the promising agents for the prevention and treatment of CI in these patients.

About the Author

Natalia Vyacheslavovna Pizova
Department of Neurology and Medical Genetics with Course of Neurosurgery, Yaroslavl State Medical Academy, Ministry of Health of Russia
Russian Federation


References

1. <div><p>Gottesman RF, Hillis AE. Predictors and assessment of cognitive dysfunction resulting from ischaemic stroke. Lancet Neurol. 2010;9(9):895–905. DOI: 10.1016/S1474-4422(10)70164-2.</p><p>Rasquin SM, Lodder J, Ponds RW et al. Cognitive functioning after stroke: a one-year follow-up study. Dement Geriatr Cogn Disord. 2004;18(2):138–44. Epub 2004 Jun 18. DOI: 10.1159%2F000079193.</p><p>Tham W, Auchus AP, Thong M et al. Progression of cognitive impairment after stroke: one year results from a longitudinal study of Singaporean stroke patients. J Neurol Sci. 2002;203–4:49–52.</p><p>Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001;8(6):621–7. DOI: 10.1046%2Fj.1468-1331.2001.00332.x.</p><p>Bejot Y, Aboa-Eboule C, Durier Jerome et al. Prevalence of early dementia after first-ever stroke: a 24-year population-based study. Stroke. 2011;42(3):607–12. DOI: 10.1161%2FSTROKEAHA.110.595553. Epub 2011 Jan 13.</p><p>Ukraintseva S, Sloan F, Arbeev K, Yashin A. Increasing rates of dementia at time of declining mortality from stroke. Stroke. 2006;37(5):1155–9. DOI: 10.1161%2F01.STR.0000217971.88034.e9. Epub 2006 Apr 6.</p><p>Jaillard A, Naegele B, Trabucco-Miguel S et al. Hidden dysfunctioning in subacute stroke. Stroke. 2009;40(7):2473–9. DOI:10.1161%2FSTROKEAHA.108.541144. Epub 2009 May 21.</p><p>Kokmen E, Whisnant JP, O’Fallon WM et al. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology. 1996;46(1):154–9. DOI: 10.1212%2FWNL.46.1.154.</p><p>Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and metaanalysis. Lancet Neurol. 2009;8(11):1006–18. DOI: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24.</p><p>Ivan CS, Seshadri S, Beiser A et al. Dementia after stroke: the Framingham Study. Stroke. 2004;35(6):1264–8. Epub 2004 Apr 29. DOI: 10.1161%2F01.STR.0000127810.92616.78.</p><p>Savva GM, Stephan BC. Alzheimer’s Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke. 2010;41(1):e41–6. DOI: 10.1161/STROKEAHA.109.559880. Epub 2009 Nov 12.</p><p>Vermeer SE, Prins ND, den Heijer T et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22. DOI: 10.1056%2FNEJMoa022066.</p><p>Бойко АН, Батышева ТТ, Багирь ЛВ и др. Опыт амбулаторного применения препарата церепро при ишемическом инсульте в раннем восстановительном периоде. Журнал неврологии и психиатрии им. С.С. Корсакова. 2007;107(10):34–40. [Boiko AN, Batysheva TT, Bagir LV et al. The experience of the use of cerepro in the treatment of outpatients in the early period of rehabilitation of is ischemic stroke. Neuroscience and Behavioral Physiology. 2007;107(10):34–40.]</p><p>Климов ЛВ, Парфенов ВА. Когнитивные нарушения в остром периоде ишемического инсульта. Неврологический журнал. 2006;11(S1):53–7. [Klimov LV, Parfenov VA. Cognitive impairment inthe acute period of ischemic stroke. Nevrologicheskiy zhurnal. 2006;11(S1):53–7.]</p><p>Дамулин ИВ. Когнитивные нарушения сосудистого генеза: клинические и терапевтические аспекты. Трудный пациент. 2006;4(7):53–8. [Damulin IV. Kognitivnye narusheniya sosudistogo geneza: klinicheskie i terapevticheskie aspekty. Trudnyy patsient. 2006;4(7):53–8.]</p><p>Tatemichi TK, Desmond DW, Mayeux R et al. Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology. 1992;42(6):1185–93. DOI: 10.1212%2FWNL.42.6.1185.</p><p>Greenberg SM. Memory, executive function, and dementia. Stroke recovery and rehabilitation. Stein J, Harvey RL, Macko RF et al., editors. New York, USA: Demos Medical Publishing; 2009. P. 213–220.</p><p>Tatemichi TK, Paik M, Bagiella E et al. Dementia after stroke is a predictor of long-term survival. Stroke. 1994;25(10):1915–9. DOI: 10.1161%2F01.STR.25.10.1915.</p><p>Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J. Neurol. 1997;244(3):135–42. DOI:10.1007%2Fs004150050064.</p><p>Виленский БС, Семенова ГМ. Причины смерти вследствие инсульта и возможные меры для снижения летальности. Журн. неврологии и психиатрии им. С.С.Корсакова 2000;5(4):10–3. [Vilenskiy BS, Semenova GM. Prichiny smerti vsledstvie insul'ta i vozmozhnye mery dlya snizheniya letal'nosti. Neuroscience and Behavioral Physiology. 2000;5(4):10–3.]</p><p>Barclay LL, Zemcov A, Blass JP, Sansone J. Survival in Alzheimer's disease and vascular dementias. Neurology. 1985;35(6):834–40. DOI: 10.1212%2FWNL.35.6.834.</p><p>Jellinger KA. Morphologic diagnosis of «vascular dementia»: a critical update. J Neurol Sci. 2008;270(1–2):1–12. DOI: 10.1016/j.jns.2008.03.006. Epub 2008 May 2.</p><p>Schneider JA, Aggarwal NT, Barnes L et al. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimers Dis. 2009;18(3):691–701. DOI: 10.3233/JAD-2009-1227.</p><p>Schneider JA, Wilson RS, Cochran EJ et al. Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology. 2003;60(7):1082–8. DOI: 10.1212%2F01.WNL.0000055863.87435.B2.</p><p>Sonnen JA, Larson EB, Crane PK et al. Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol. 2007;62(4):406–13. DOI: 10.1002%2Fana.21208.</p><p>White L, Small BJ, Petrovitch H et al. Recent clinicalpathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol. 2005;18(4):224–7.</p><p>Gorelick PB, Scuteri A, Black SE et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672–713. DOI: 10.1161/STR.0b013e3182299496. Epub 2011 Jul 21.</p><p>Яхно НН, Захаров ВВ, Локшина АБ и др. Деменции: руководство для врачей. Москва: МЕДпреcс-информ; 2011; 272 с. [Yakhno NN, Zakharov VV, Lokshina AB i dr. Dementsii: rukovodstvo dlya vrachey. Moscow: MEDprecs-inform; 2011; 272 p.]</p><p>Vinters HV, Ellis WG, Zarow C et al. Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol. 2000;59(11):931–45.</p><p>Desmond DW, Moroney JT, Paik MC et al. Frequency and clinical determinants of dementia after ischemic stroke. Neurology. 2000;54(5):1124–31. DOI: 10.1212%2FWNL.54.5.1124.</p><p>Pohjasvaara T, Mantyla R, Salonen O et al. How complex interactions of ischemic brain infarcts, white matter lesions, and atrophy relate to poststroke dementia. Arch Neurol. 2000;57(9):1295–300. DOI: 10.1001%2Farchneur.57.9.1295.</p><p>Ballard CG, Burton EJ, Barber R et al. NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology. 2004;63(6):983–8. DOI: 10.1212%2F01.WNL.0000138435.19761.93.</p><p>Van Kooten F, Bots ML, Breteler MM et al. The Dutch Vascular Factors in Dementia Study: rationale and design. J Neurol. 1998;245(1):32–9. DOI: 10.1007%2Fs004150050171.</p><p>Srikanth VK, Quinn SJ, Donnan GA et al. Long-term cognitive transitions, rates of cognitive change, and predictors of incident dementia in a populationbased first-ever stroke cohort. Stroke. 2006;37(10):2479–83. Epub 2006 Aug 31.</p><p>Henon H, Durieu I, Lebert F et al. Influence of pre-stroke dementia on early and delayed mortality in stroke patients. J Neurol 2003;250(1):10–6.</p><p>Van Kooten F, Koudstaal PJ. Epidemiology of post-stroke dementia. Haemostasis. 1998;28(3–4):124–33.</p><p>Sachdev PS, Brodaty H, Valenzuela M et al. Clinical determinants of dementia and mils cognitive impairment following ischemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord. 2006;21(5–6):275–83. Epub 2006 Feb 10.</p><p>Pendlebury ST, Rothwell PM. Prevalence, incidence and factors associated with prestrike and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol. 2009;8(11):1006–18. DOI: 10.1016/S1474-4422(09)70236-4. Epub 2009 Sep 24.</p><p>Pasquier F, Henon H, Leys D. Risk factors and mechanisms of post-stroke dementia. Rev Neurol (Paris). 1999;155(9):749–53.</p><p>Firbank M, Burton EJ, Barbur R et al. Medial temporal atrophy rather than white matter hyperintensities predicts cognitive decline in stroke survivors. Neurobiol Aging. 2007;28(11):1664–9. DOI: 10.1016%2Fj.neurobiolaging.2006.07.009. Epub 2006 Aug 24.</p><p>Barba R, Martinez-Espinosa S, Rodriguez-Garcia E et al. Poststroke dementia: clinical features and risk factors. Stroke. 2000;31(7):1494–501. DOI: 10.1161%2F01.STR.31.7.1494.</p><p>Левин ОС, Усольцева НИ, Юнищенко НA. Постинсультные когнитивные нарушения: механизмы развития и подходы к лечению. Трудный пациент. 2007;5(8):26–9. [Levin OS, Usol'tseva NI, Yunishchenko NA. Postinsul'tnye kognitivnye narusheniya: mekhanizmy razvitiya i podkhody k lecheniyu. Trudnyy patsient. 2007;5(8):26–9.]</p><p>Fariello RG. Treatment of impaired cognition with nootropic drugs: nicergoline versus the state of the art. Funct Neurol. 1997;12(3–4):221–5.</p><p>Winblad B, Fioravanti M, Dolezal T et al. Therapeutic use of nicergoline. Clin Drug Invest. 2008;28(9):533–52. DOI: 10.2165%2F00044011-200828090-00001.</p><p>Winblad B, Carfagna N, Bonura L et al. Nicergoline in dementia. A review of its pharmacological properties and therapeutic potential. CNS Drugs. 2000;14(4):267–87. DOI: 10.2165%2F00023210-200014040-00003.</p><p>Iliff LD, Du Boulay GH, Marshall J et al. Effect of nicergoline on cerebral blood flow. J Neurol Neurosurg Psychiatry. 1977;40(8):746–7. DOI: 10.1136%2Fjnnp.40.8.746.</p><p>Kurosu S, Mori Y, Kobayashi N et al. Relationship of ERP to intellectual function and cerebral blood flow following Sermion (nicergoline) treatment in patients with cerebrovascular dementia. Pharma Medica. 2002;20(9):231–6.</p><p>Elwan O, Helmy AA, Tamawy ME et al. Ergoloids and ischaemic strokes; efficacy and mechanism of action. J Int Med Res. 1995;23(3):154–66.</p><p>Zylberman MR, Fontana M, Dolce G. Effects of nicergoline on learning, mood and behaviour in hemiplegic patients undergoing rehabilitation. In: Kugler J, Agnoli A, editors. Ergot alkaloids and aging brain: an update on nicergoline. Amsterdam: Excerpta Medica; 1988:57–63.</p><p>Novellini R, Battaglia A, Pamparana F. Rehabilitation training and drug treatment in after stroke patients: a comparison nicergoline and piracetam [abstract]. XIV World Congress of Neurology; 1989. P. 7–22.</p><p>Kohashi N, Sakatani T, Kumon Y et al. Quality of Life (QoL) elderly cerebrovascular disorder patients treated with a combination of rehabilitation training and nicergoline. J Hyogo Med Assoc. 1997;39(3):136.</p><p>Kamizaki Y. Sermion (nicergoline) therapy for sleeplessness associated with cerebrovascular disease. Pharma Medica. 2004;22(3):169–75.</p><p>Katsumata T, Katayama Y. Treatment by medicine which improves cerebral circulation and metabolism. Nihon Rinsho. 2006;64 Suppl 8:81–4.</p><p>Nappi G, Bono G, Merlo P et al. Long-term nicergoline treatment of mild to moderate senile dementia: results of a multicentre, double-blind, placebo-controlled study. Clin Drug Invest. 1997;13(6):308–16. DOI: 10.2165%2F00044011-199713060-00003.</p></div><br />


For citation:


Pizova N.V. Post-stroke cognitive impairments: diagnosis and therapeutic approaches. Neurology, Neuropsychiatry, Psychosomatics. 2013;5(2S):56-61. (In Russ.) https://doi.org/10.14412/2074-2711-2013-2360

Views: 569


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)